BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2739500)

  • 1. [Etiopathogenesis of progressive systemic sclerosis].
    Markeljević J; Horvat Z
    Lijec Vjesn; 1989; 111(1-2):43-6. PubMed ID: 2739500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudovitiligo in Systemic Sclerosis.
    Rai VM; Balachandran C
    Dermatol Online J; 2005 Dec; 11(3):41. PubMed ID: 16409937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G
    Acta Med Acad Sci Hung; 1978; 35(3-4):201-11. PubMed ID: 756110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis].
    Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2006 Apr; 2(62):1052-7. PubMed ID: 16711150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of skin scleroderma--literature review].
    Wojas-Pelc A; Lipko-Godlewska S
    Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of scleroderma: an update.
    Haustein UF; Anderegg U
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):1-8. PubMed ID: 9731958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis-scleroderma.
    Haustein UF
    Dermatol Online J; 2002 Jun; 8(1):3. PubMed ID: 12165213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
    Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
    Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological basis of systemic sclerosis.
    Zuber JP; Spertini F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for lysophosphatidic acid and sphingosine 1-phosphate in the pathogenesis of systemic sclerosis.
    Pattanaik D; Postlethwaite AE
    Discov Med; 2010 Aug; 10(51):161-7. PubMed ID: 20807477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis. Which therapies?].
    Bettoni L
    Minerva Med; 2001 Apr; 92(2):121-7. PubMed ID: 11323574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma).
    Nguyen VA; Sgonc R; Dietrich H; Wick G
    J Autoimmun; 2000 Mar; 14(2):143-9. PubMed ID: 10677245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
    Buckingham RB; Prince RK; Rodnan GP
    J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy in scleroderma.
    Corbo M; Nemni R; Iannaccone S; Quattrini A; Lodi M; Praderio L; Comola M; Lorenzetti I; Comi G; Canal N
    Clin Neuropathol; 1993; 12(2):63-7. PubMed ID: 8386601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic sclerosis: symptomatic treatment].
    Dziankowska-Bartkowiak B; Waszczykowska E; Skretkowicz K
    Pol Merkur Lekarski; 2003 Sep; 15(87):259-62. PubMed ID: 14679853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of scleroderma].
    Fleischmajer R; Perlish JS; Maquart FX; Kalis B
    Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.